PMHS
Polomar Health Services, Inc.
Key Financials
Revenue
$58824
↑ 40.6%
Operating Income
$-1299496
↓ 381.6%
Gross Profit
$30903
↓ 17.7%
Total Liabilities
$1.4M
↑ 9713.8%
EPS (Diluted)
$-0.05
↓ 150.0%
Shareholders' Equity
$8.6M
↑ 63613.8%
Net Income
$-1341333
↓ 222.0%
Total Assets
$10.0M
↑ 4078495.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| NT 10-K | 4/1/2026 | View on SEC |
| DEFM14C | 3/12/2026 | View on SEC |
| DEF 14C | 2/17/2026 | View on SEC |
| PRER14C | 2/17/2026 | View on SEC |
| PRE 14C | 2/5/2026 | View on SEC |
| 424B3 | 12/19/2025 | View on SEC |
| EFFECT | 12/12/2025 | View on SEC |
| 8-K | 12/12/2025 | View on SEC |
| S-1/A | 12/8/2025 | View on SEC |
| S-1/A | 12/5/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PMHS |
| Company Name | Polomar Health Services, Inc. |
| CIK | 1265521 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 800-490-7454 |